Results for the first quarter 2019 for Medistim ASA

Sales for the quarter ended at MNOK 88.7 (MNOK 74.1), a 19,7 % increase. The growth was driven by USA where sales increased with 50 % in NOK compared to last year. Currency neutral sales of own products increased with 20.0 %, while currency neutral sales in the US increased with 37.3 %. Strong growth in capital sale of systems in the US contributes to sales growth for the quarter and future increased recurring revenue. Operating profit (EBIT) ended at MNOK 19.9 (MNOK 13.6). The General Meeting decided to pay a dividend of NOK 2.25 per share (NOK 2.00 per share).